- Frequency: Monthly issues, published continuously online
- Impact factor: 16.102
- e-ISSN: 0003-4967
- First published: 1939
- Editor-in-Chief: Josef Smolen, MD, Medical University of Vienna
- Website: ard.bmj.com
The home for innovative rheumatology research
Annals of the Rheumatic Diseases (ARD) is committed to promoting the highest standards of scientific exchange and education. Its international, peer-reviewed content covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders.
Content includes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.
ARD is an official journal of EULAR.
Ranked #2 in Rheumatology and #3 in General Biochemistry, Genetics & Molecular Biology
ARD seeks to publish significant scientific advances that influence and impact clinical practice. Articles illustrating basic mechanisms and their application to clinical material are welcome. The journal aims to cover all areas of rheumatology and the priorities are originality and excellence.
An institutional subscription includes archive access dating back to 1939, when the journal first published.
Article types include:
• Original research – extended report and concise report • Review • Recommendations and criteria • Editorial • Viewpoint • Video • …and more!
Call 1+ (855) 458-0579 or email email@example.com to request a quote.